Weka Biosciences, LLC
June 25, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Tools/Drug Development Support Tech
Weka Biosciences is a Santa Fe, NM-based enzyme innovation company developing novel polysaccharide polymers with applications spanning chromatography and therapeutics. Our platform produces a non-sulfated, all-α-linked glycosaminoglycan commercialized as Nextan™ (800 kDa–1.2 MDa, recombinant microbial production) and Testan™ (10–100 kDa, chemoenzymatic, size-defined). Nextan™ is purpose-built as a next-generation chiral stationary phase backbone, complementing cellulose- and amylose-based columns with a new selectivity profile. Sulfated derivatives of our polymer also show therapeutic promise, opening a longer-horizon pipeline in drug development. Weka is NSF SBIR-funded and advancing toward commercial partnerships with leading chromatography manufacturers.
Company HQ City:
Santa Fe
Company HQ State:
NM
Company HQ Country:
United States
Year Founded:
2014
CEO
Nigel Otto
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}